Singapore Chronic Cough Therapeutics Market Analysis

Singapore Chronic Cough Therapeutics Market Analysis

$ 3999

Singapore Chronic Cough Therapeutics Market was valued at $8 Mn in 2022 and is estimated to reach $15 Mn in 2030, exhibiting a CAGR of 8.7% during the forecast period. The predominant factor driving the growth of the chronic cough therapeutics market is the prevalent occurrence of persistent coughing associated with chronic respiratory infections. Leading entities in this sector currently include Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Hikma Pharmaceuticals, and Abbott Laboratories.

CATEGORY: Pharmaceuticals GEOGRAPHY: Singapore AUTHOR: Medha Sansanwal

Buy Now

Singapore Chronic Cough Therapeutics Market Executive Summary

Singapore Chronic Cough Therapeutics Market was valued at $8 Mn in 2022 and is estimated to reach $15 Mn in 2030, exhibiting a CAGR of 8.7% during the forecast period.

A chronic cough is characterized by its persistence for more than eight weeks, setting it apart from short-term coughs associated with temporary conditions. In contrast to transient coughs typically linked to infections, a chronic cough may indicate a prolonged underlying health issue. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease (GERD), postnasal drip, and certain medications are common culprits behind chronic cough. It is crucial to identify and address the underlying cause through a comprehensive medical evaluation for effective management. Chronic cough can significantly impact the quality of life, often necessitating a holistic, multidisciplinary approach that involves healthcare professionals like pulmonologists, gastroenterologists, or ear, nose, and throat (ENT) specialists.

In Singapore, chronic cough emerges as a prevalent reason leading to referrals to respiratory physicians, constituting the most frequent presentation in approximately 25% of general practitioner and polyclinic visits. Among the non-smoking adult population, the prevalence of chronic cough ranges from 14-23%. Significant contributors to chronic cough in this context include postnasal drip syndrome, postinfectious cough, gastro-oesophageal reflux disease, and cough variant asthma. Less common triggers involve the use of angiotensin-converting enzyme inhibitors, smoker's cough, and non-asthmatic eosinophilic bronchitis. While chronic cough is generally not life-threatening, it carries the potential for rare but serious complications, including pneumothorax, syncope, and cardiac arrhythmias.

The National University of Singapore (NUS) and GlaxoSmithKline (GSK) have joined forces in a research collaboration for a $4.7 Mn project. This initiative aims to explore the role of the microbiome in respiratory diseases, with a specific focus on chronic cough.

The Agency for Science, Technology, and Research (A*STAR) directs its efforts toward the advancement of new technologies dedicated to the diagnosis and treatment of respiratory diseases. Their research encompasses potential applications for addressing chronic cough, reflecting a commitment to innovative approaches in the field.

Singapore Chronic Cough Therapeutics Market Report 2022 to 2030

Market Dynamics

Market Growth Drivers

Aging population: As of 2022, 16.6% of Singapore's resident population comprises individuals aged 65 years and above. Projections indicate that this percentage is anticipated to increase to 23.8% by the year 2030 and further escalate to 36% by 2050. The aging demographic in Singapore is particularly vulnerable to chronic cough, primarily attributed to underlying health conditions such as asthma, chronic obstructive pulmonary disease (COPD), and gastroesophageal reflux disease (GERD). This ongoing demographic shift toward an older population is foreseen to persist, contributing significantly to the continued growth of the market for chronic cough therapeutics.

Changing Lifestyles and Environmental Factors: Evolving lifestyles, urbanization, and exposure to environmental pollutants contribute to the escalation of respiratory disorders, necessitating a higher demand for chronic cough therapeutics.

Awareness and Diagnosis Improvement: Heightened awareness regarding chronic cough symptoms and advancements in diagnostic capabilities lead to more accurate and timely identification of the condition, fostering the demand for therapeutic interventions.

Market Restraints

Cultural Perceptions and Traditional Remedies: In Singapore, people might turn to homeopathic or traditional remedies influenced by cultural attitudes and preferences, impacting their perception of persistent coughs. Encouraging the acceptance of modern treatment alternatives among both healthcare professionals and patients could present a challenge for the industry.

Side Effects and Safety Concerns: Potential side effects or safety concerns associated with certain chronic cough therapeutics may raise apprehensions among both healthcare providers and patients. This could lead to a more cautious adoption of these treatments, impacting market growth.

Reliance on Symptomatic Treatment: The predominant use of symptomatic treatment approaches for chronic cough, rather than addressing the underlying causes, may limit the effectiveness of available therapeutics. This reliance on managing symptoms rather than curing the root cause can be a constraint in achieving long-term success.

Healthcare Policies and Regulatory Landscape

The Health Sciences Authority (HSA), as the primary regulatory body ensuring the safety and quality of health products, plays a crucial role in overseeing Singapore's regulatory landscape and healthcare regulations governing therapeutic pharmaceuticals. The Ministry of Health (MOH), in collaboration with HSA, is instrumental in establishing healthcare standards and policies. The Pharmacy Practice Act provides guidelines for drug distribution, overseeing both pharmacy practices and the sale of therapeutic products. The National Medicines Policy (NMP), integrated into the broader healthcare policy framework, guides the distribution and control of pharmaceuticals. Additionally, payment regulations may be influenced by health insurance coverage, such as the Central Provident Fund (CPF) and various health insurance plans, potentially impacting patients' access to specific treatment medications.

Competitive Landscape

Key Players

  • Pfizer
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Novartis
  • AstraZeneca
  • Boehringer Ingelheim
  • Teva Pharmaceuticals
  • Hikma Pharmaceuticals
  • Abbott Laboratories

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Singapore Chronic Cough Therapeutics Market Segmentation

By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
  • Others

By Route of Administration

  • Oral
  • Inhalational
  • Injectable
  • Others

By End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 06 June 2024
Updated by: Dr. Purav Gandhi

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter